Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 03 Dec 2013  |  North America

    Analysis of the Global Tissue Diagnostics Market

    Reimbursement Cuts and Hospital Consolidation Impede Uptake of Automated Equipment in Laboratories

    This study investigates the global tissue diagnostics market for the period 2009 to 2017. The geographic regions are the US, Western Europe, APAC, and ROW through which the market is broadly classified by the advance stains segment and the pre-analytical segment. The study also includes a competitive analysis (SWOT), product analysis, revenue forec...

    $10,000.00
  2. 26 Sep 2013  |  North America

    US Medical Radiopharmaceuticals Market

    New Growth Opportunities Emerge in a Strenuous Market

    This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as wit...

    $4,950.00
  3. 02 Sep 2013  |  North America

    Global Analysis of MicroRNA Tools and Services Market

    Evolving microRNA Market Provides an Opportunity for Vendors of qRT-PCR and Functional Tools

    The overall research objective was to capture and analyze global next-generation (NGS) sequencing trends and use. Most researchers outsource NGS technologies; however, in-house NGS technology use is expected to increase within the next 12 months. Data accuracy and operating costs are the top criteria for purchasing sequencing instruments. Disease-r...

    $10,000.00
  4. 11 Jul 2013  |  North America

    2012 United States Radiology Directors’ Choice: Medical Imaging Equipment

    Determining Brand Perceptions and Preferences

    The primary objective of this research is to assess the behavior of North American radiology directors as well as their preferences regarding radiology departments use of medical imaging equipment and services. Supporting the primary objective, this research will also: determine titles of medical equipment purchasers (executives, directors, and man...

    $10,000.00
  5. This issue of Vital Signs published June 30, 2013, provides a global overview of market trends and expected growth of the Point-of-care Testing (POCT) market.

    $1,500.00
  6. 27 Jun 2013  |  North America

    2013 Global Medical Imaging Equipment Market Outlook

    Positioning for the Future

    This outlook analyzes trends and revenue in the global medical imaging equipment market from 2012 to 2017. The market is segmented by geographic region and by medical imaging modality, with 10 regional and 7 modality segments evaluated. The modalities evaluated are general X-ray, mammographic X-ray, interventional X-ray, CT, ultrasound, MR, and mol...

    $4,950.00
  7. 27 Jun 2013  |  North America

    Global Mass Spectrometry Market

    Technological Advancements Drive Demand in Diverse Applications

    This research service evaluates the global mass spectrometry market from 2010 to 2017. Regions analyzed include the US, Europe, Asia-Pacific (APAC), and Rest of World (ROW) combined. Technology segments analyzed include single quadrupole LC/MS, tandem LC/MS, time-of-flight LC/MS, and MALDI-TOF-MS. The mature market remains dynamic due to a technolo...

    $4,950.00
  8. This issue of Vital Signs, released on June 30, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

    $1,500.00
  9. 03 Jun 2013  |  North America

    US and European Digital Pathology Systems Market

    Growth in Digital Pathology is Slow but Promising and is Poised to Reshape Anatomic Pathology

    The research service provides an overview of the US and the European digital pathology systems market and provides a 7-year forecast from 2013 to 2019. For the purpose of this study, digital pathology is defined as those systems, applications, and services that provide a digital environment for the management and interpretation of pathology studies...

    $4,950.00
  10. 31 May 2013  |  North America

    Global Autoimmune Disease Diagnostics Market

    This research service evaluates the global autoimmune disease diagnostics markets from 2009 to 2018. The market includes two segments, which include analysis for the markets for localized autoimmune disease diagnostic tests and for the systemic autoimmune disease diagnostic tests. This research service offers a discussion of the key market drivers ...

    $4,950.00